AI FOR DERMATOLOGY
(Skin AI GROUP)
Encouraged by our early results in Acne AI, Skin Cancer AI and other projects, on July 4th 2021 we officially co-founded with our partners the US-based company Belle Torus Corp. (Belle.ai) to develop and commercialize AI-based solutions for dermatology and dermocosmetics.
We also co-founded Torus Engineering Vietnam (TEV) to take care of the engineering part of it. The Skin AI group at Torus, helped by the other groups, takes care of the creation of core AI modules in this vast project.
Together with our partners and medical doctors, we have created 40+ dermatology AI modules, from the detection of thousands (almost all) skin diseases to the detailed segmentation and severity scoring of common diseases such as acne, eczema, psoriasis, vitiligo, alopecia areata, etc.
BelleTorus counts among its customers and partners many pharmaceutical companies, CROs, private and public hospitals, governemental organizations and NGOs around the world, including WHO (World Health Organization) and NIH (National Institutes of Health):
Belle.ai has been awarded a US patent for PASI AI (AI-aided psoriasis severity scoring). Other patents are pending.
Torus is a member of the European Research Council’s (ERC) Horizon 2020 project, named iToBoS, for skin cancer detection. In 2019, when we just started the work on AI for dermatology, our team won the 1st Runner-Up Prize in the ISIC 2019 International Challenge of Skin Cancer detection.